But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...

Penserra Capital Management LLC reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 88.3% in the ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, includ ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...